
    
      This clinical trial wants to study the safety, effectiveness and efficacy of NK cells
      incubated infusion (CD56 +, CD3) incubated ex vivo with IL-15 infusion in patients with high
      risk acute myeloid leukemia undergoing allogeneic transplant of an haploidentical donor with
      post-transplant cyclophosphamide administration.
    
  